GSK-200952

Study Sponsor: GSK

Study Title

A Repeat-dose Study in Subjects with Type 2 Diabetes Mellitus to Assess the Efficacy, Safety, Tolerability and Pharmacodynamics, of Albiglutide Liquid Drug Product

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

200952

Trial Registry Identification Number(#'s)

NCT02683746

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200952

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02683746

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. The data for this study is available in CDISC format. Data for some subjects is not available due to lack of consent.

Date Added to this Site

May 2019